Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Sarcopenia 1Prediabetic State 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Nervous System Diseases 1Neoplasms 1Myelodysplastic Syndromes 1Muscle Weakness 1Leukemia, Myeloid 1Hematologic Neoplasms 1Heart Failure 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Cardiotoxicity 1Breast Neoplasms 1Anemia, Aplastic 1

Interventions

Creatine 2telitacicept 1nicotinamide-beta-riboside 1fludarabine 1Testosterone 1Telemedicine 1Positron-Emission Tomography 1Magnetic Resonance Imaging 1Exercise Movement Techniques 1Eicosapentaenoic Acid 1Cyclophosphamide 1Carnitine 1Caloric Restriction 1Blood Specimen Collection 1Autogenic Training 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Muscle Weakness × nicotinamide-beta-riboside × Clear all
NCT03789175 2020-12-08

Nicotinamide Riboside on Mitochondrial Function in Li-Fraumeni Syndrome

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
1 enrolled 7 charts

Neoplasms, Muscle Weakness

Data powered by HemOnc (CC BY 4.0) Colophon âš¡